Skip to content

Effects of cupping therapy on pain intensity, fatigue and performance after a 10km run

Effects of sliding cupping therapy on pain intensity, fatigue perception and muscular performance after a 10km run

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10fg77vk
Enrollment
Unknown
Registered
2022-01-28
Start date
2023-07-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Fatigue

Interventions

This is a controlled, randomized and blind clinical trial, in which 60 runners, men and women, from the metropolitan region of Natal will be recruited, which will be divided into 3 groups, with 20 vol

Sponsors

Universidade Federal do Rio Grande do Norte - Faculdade de Ciências da Saúde do Trairí
Lead Sponsor
Caio Alano de Almeida Lins
Collaborator

Eligibility

Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Street runners for at least 1 year who run twice a week; Being able to run 10 km continuously in the time interval between 40 and 60 minutes in at least one training session; Be between 18 and 45 years old; Not present severe cardiorespiratory or metabolic alterations, proven by a medical report; Not reporting the presence of musculoskeletal disorders in the lower limbs, in the last 6 months, that have prevented the maintenance of the training routine; Do not report any of the contraindications for the application of cupping therapy; Never having used cupping therapy

Exclusion criteria

Exclusion criteria: Presenting disorders in the quadriceps femoris, such as hematoma and cramp, during study procedures; Present allergy or skin irritation due to the use of vegetable oil necessary for cupping therapy; Not being able to complete the 10km run within 60 minutes; Failure to correctly perform the assessment procedures; Not attending any stages of collection development; Make use of anti-inflammatory drugs, corticosteroids, analgesics or muscle relaxants during the collection period or in the 30 days preceding the beginning of the study; Make use of ergogenic resources, such as anabolic steroids, in the last 6 months prior to the start of collection; Carry out another type of intervention for muscle recovery during the development of the research; Refusing to sign the Free and Informed Consent Form (ICF)

Design outcomes

Primary

MeasureTime frame
Evaluate pain and fatigue intensity using an analog scale

Secondary

MeasureTime frame
Assess muscle pain through algometry with an algometer.;To evaluate isometric strength and power of the quadriceps femoris, using isokinetic dynamometry with an isokinetic dynamometer and vertical jump using a jumping mat.;Assess perception of recovery through total recovery quality scale.

Countries

Brazil

Contacts

Public ContactCaio Alano de Lins

Universidade Federal do Rio Grande do Norte - Faculdade de Ciências da Saúde do Trairí

caiouzl@hotmail.com+55-084-996810444

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 8, 2026